These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 24885955

  • 1. Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinoma.
    Roos FC, Steffens S, Junker K, Janssen M, Becker F, Wegener G, Brenner W, Steinestel J, Schnoeller TJ, Schrader M, Hofmann R, Thüroff JW, Kuczyk MA, Wunderlich H, Siemer S, Hartmann A, Stöckle M, Schrader AJ, German Renal Cell Cancer Network.
    BMC Cancer; 2014 May 26; 14():372. PubMed ID: 24885955
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM, Kates M, Wisnivesky JP, Choudhury AR, McKiernan JM.
    BJU Int; 2012 May 26; 109(10):1457-62. PubMed ID: 21933334
    [Abstract] [Full Text] [Related]

  • 4. Comparison of prognosis between patients undergoing radical nephrectomy versus partial nephrectomy for renal cell carcinoma ≤7 cm T3aN0/xM0: Survival benefit is biased toward partial nephrectomy.
    Liu S, Feng C, Liu C, Wang Z.
    Cancer Med; 2021 Dec 26; 10(24):8909-8923. PubMed ID: 34779154
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
    Crépel M, Jeldres C, Sun M, Lughezzani G, Isbarn H, Alasker A, Capitanio U, Shariat SF, Arjane P, Widmer H, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.
    Urology; 2010 Oct 26; 76(4):883-8. PubMed ID: 20932408
    [Abstract] [Full Text] [Related]

  • 9. A non-cancer-related survival benefit is associated with partial nephrectomy.
    Sun M, Trinh QD, Bianchi M, Hansen J, Hanna N, Abdollah F, Shariat SF, Briganti A, Montorsi F, Perrotte P, Karakiewicz PI.
    Eur Urol; 2012 Apr 26; 61(4):725-31. PubMed ID: 22172373
    [Abstract] [Full Text] [Related]

  • 10. Percutaneous Ablation Versus Partial and Radical Nephrectomy for T1a Renal Cancer: A Population-Based Analysis.
    Talenfeld AD, Gennarelli RL, Elkin EB, Atoria CL, Durack JC, Huang WC, Kwan SW.
    Ann Intern Med; 2018 Jul 17; 169(2):69-77. PubMed ID: 29946703
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma-Analysis of a national cancer registry.
    Venkatramani V, Koru-Sengul T, Miao F, Nahar B, Prakash NS, Swain S, Punnen S, Ritch C, Gonzalgo M, Parekh D.
    Urol Oncol; 2018 Mar 17; 36(3):90.e9-90.e14. PubMed ID: 29254672
    [Abstract] [Full Text] [Related]

  • 14. Overall survival advantage with partial nephrectomy: a bias of observational data?
    Shuch B, Hanley J, Lai J, Vourganti S, Kim SP, Setodji CM, Dick AW, Chow WH, Saigal C, Urologic Diseases in America Project.
    Cancer; 2013 Aug 15; 119(16):2981-9. PubMed ID: 23674264
    [Abstract] [Full Text] [Related]

  • 15. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
    Mir MC, Derweesh I, Porpiglia F, Zargar H, Mottrie A, Autorino R.
    Eur Urol; 2017 Apr 15; 71(4):606-617. PubMed ID: 27614693
    [Abstract] [Full Text] [Related]

  • 16. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
    Van Poppel H, Da Pozzo L, Albrecht W, Matveev V, Bono A, Borkowski A, Colombel M, Klotz L, Skinner E, Keane T, Marreaud S, Collette S, Sylvester R.
    Eur Urol; 2011 Apr 15; 59(4):543-52. PubMed ID: 21186077
    [Abstract] [Full Text] [Related]

  • 17. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
    Nguyen DP, Vertosick EA, Corradi RB, Vilaseca A, Benfante NE, Touijer KA, Sjoberg DD, Russo P.
    Urol Oncol; 2016 Jun 15; 34(6):259.e1-8. PubMed ID: 26947350
    [Abstract] [Full Text] [Related]

  • 18. Comparison of outcomes of radical and partial nephrectomy for sarcomatoid renal cell carcinoma: analysis of the national cancer database.
    Wang LL, Yuen KL, Saitta C, Meagher MF, Liu F, Guer M, Puri D, Chen YW, Javier-Desloges J, McKay RR, Derweesh IH.
    World J Urol; 2024 Sep 06; 42(1):508. PubMed ID: 39240329
    [Abstract] [Full Text] [Related]

  • 19. Comparison of survival rates in stage 1 renal cell carcinoma between partial nephrectomy and radical nephrectomy patients according to age distribution: a propensity score matching study.
    Takagi T, Kondo T, Iizuka J, Omae K, Kobayashi H, Yoshida K, Hashimoto Y, Tanabe K.
    BJU Int; 2016 Jun 06; 117(6B):E52-9. PubMed ID: 26073989
    [Abstract] [Full Text] [Related]

  • 20. Can partial nephrectomy provide equal oncological efficiency and safety compared with radical nephrectomy in patients with renal cell carcinoma (≥4cm)? A propensity score-matched study.
    Lee H, Oh JJ, Byun SS, Jeong CW, Kwak C, Jeong BC, Jeon SS, Lee HM, Choi HY, Seo SI.
    Urol Oncol; 2017 Jun 06; 35(6):379-385. PubMed ID: 28284894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.